2024-04-01 2025-03-31 false Capium Accounts Production 1.1 11905445 2024-04-01 2025-03-31 11905445 bus:AbridgedAccounts 2024-04-01 2025-03-31 11905445 bus:FRS102 2024-04-01 2025-03-31 11905445 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11905445 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11905445 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11905445 2024-04-01 2025-03-31 11905445 2025-03-31 11905445 bus:RegisteredOffice 2024-04-01 2025-03-31 11905445 core:WithinOneYear 2025-03-31 11905445 core:AfterOneYear 2025-03-31 11905445 1 2024-04-01 2025-03-31 11905445 bus:Director1 2024-04-01 2025-03-31 11905445 bus:Director1 2025-03-31 11905445 bus:Director1 2023-04-01 2024-03-31 11905445 bus:Director2 2024-04-01 2025-03-31 11905445 bus:Director2 2025-03-31 11905445 bus:Director2 2023-04-01 2024-03-31 11905445 2023-04-01 11905445 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 11905445 2023-04-01 2024-03-31 11905445 2024-03-31 11905445 core:WithinOneYear 2024-03-31 11905445 core:AfterOneYear 2024-03-31 11905445 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 11905445 core:MotorCars 2024-04-01 2025-03-31 11905445 core:MotorCars 2025-03-31 11905445 core:MotorCars 2024-03-31 11905445 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 11905445 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 11905445 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 11905445 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 11905445 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 11905445 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 11905445 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 11905445 core:Non-currentFinancialInstruments 2025-03-31 11905445 core:Non-currentFinancialInstruments 2024-03-31 11905445 core:ShareCapital 2025-03-31 11905445 core:ShareCapital 2024-03-31 11905445 core:RetainedEarningsAccumulatedLosses 2025-03-31 11905445 core:RetainedEarningsAccumulatedLosses 2024-03-31 11905445 dpl:Item1 2024-04-01 11905445 dpl:Item1 2025-03-31 11905445 dpl:Item1 2023-04-01 11905445 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11905445
England and Wales

 

 

 

MEDICS4U.COM LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 16,940    25,410 
Investments 4 203,174    203,174 
220,114    228,584 
Current assets      
Cash at bank and in hand 16,505    69,593 
Creditors: amount falling due within one year (48,068)   (78,864)
Net current assets (31,563)   (9,271)
 
Total assets less current liabilities 188,551    219,313 
Creditors: amount falling due after more than one year (22,815)   (27,022)
Provisions for liabilities (1,803)   (3,412)
Net assets 163,933    188,879 
 

Capital and reserves
     
Called up share capital 2    2 
Profit and loss account 163,931    188,877 
Shareholders' funds 163,933    188,879 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 29 December 2025 and were signed on its behalf by:


-------------------------------
Muhammad Adnan
Director
1
General Information
Medics4u.com Ltd is a private company, limited by shares, registered in England and Wales, registration number 11905445, registration address 62 Bennett Road, Sutton Coldfield, B74 4TG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 20 Straight Line
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Total
  £   £
At 01 April 2024 61,830    61,830 
Additions  
Disposals  
At 31 March 2025 61,830    61,830 
Depreciation
At 01 April 2024 36,420    36,420 
Charge for year 8,470    8,470 
On disposals  
At 31 March 2025 44,890    44,890 
Net book values
Closing balance as at 31 March 2025 16,940    16,940 
Opening balance as at 01 April 2024 25,410    25,410 


4.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 April 2024 203,174    203,174 
Additions  
Disposals  
At 31 March 2025 203,174    203,174 

2